LEARNING OBJECTIVES
- Discuss treatment options available for high risk MDS patients
- Examine new immune based therapies, including CAR T-cell therapy, in the treatment of multiple myeloma
- Describe therapeutic and molecular strategies for managing patients with Non-Hodgkin’s lymphoma
- Examine the management of older adult patients with AML
- Recognize some of the newer issues affecting the care of Hematology patients
TARGET AUDIENCE
This conference is designed specifically for hematologists, medical oncologists, pharmacists, pharmacy techs, fellows, advanced practice professionals, oncology nurses and other healthcare professionals who are interested in this field.
Topics:
- FINAL.Heme-Conference-AGENDA-2024-v21.pdf
- Hot Off the Press Lymphoid Diseases.mp4
- Hot Off the Press Myeloid Diseases.mp4
- Hot Off the Press Plasma Cell Dyscrasias.mp4
- Lymphoid Malignancies Debate Harnessing the Immune System to Manage Relapsed Refractory Diffuse Large B Cell Lymphom No.mp4
- Lymphoid Malignancies Debate Harnessing the Immune System to Manage Relapsed Refractory Diffuse Large B Cell
- Lymphom Yes.mp4
- Lymphoid Malignancies Interactive Case Discussion Optimal Management of Patients with CLL.mp4
- Lymphoid Malignancies State of the Art Frontline Treatment of Advanced Stage Hodgkin Lymphoma.mp4
- Multiple Myeloma Debate Response-adapted approach to transplant in newly diagnosed MM are we there yet No.mp4
- Multiple Myeloma Debate Response-adapted approach to transplant in newly diagnosed MM are we there yet Yes.mp4
- Multiple Myeloma Interactive Case Discussion Optimal timing of CART-cell therapy in myeloma.mp4
- Multiple Myeloma State of the Art Bi-specifics antibodies in myeloma Which How When.mp4
- Myeloid Malignancies Debate- Worst of the worst- Should we transplant patients with p53 mutant MDS or AML Yes.mp4
- Myeloid Malignancies Interactive Case Discussion- Optimal use of targeted therapy for the elderly or unfit AML patient.mp4
- Myeloid Malignancies State of the Art- Making Sense of the New Classification Systems for MDS.mp4
Clinical Breakthroughs and Challenges
in Hematologic Malignancies
January 27, 2024
AGENDA
- 7:00-8:00 am Breakfast and Registration
8:00-8:05 am Welcome and Introductions
SESSION Lymphoid Malignancies — Moderator: Celeste Bello, MD
8:05-8:30 am State of the Art: Frontline Treatment of Advanced Stage Hodgkin Lymphoma
Hayder Saeed, MD
8:30-8:55 am Interactive Case Discussion: Optimal Management of Patients with CLL
Javier Pinilla, MD
8:55-9:25 am Debate: Harnessing the Immune System to Manage Relapsed/Refractory Diffuse Large B Cell Lymphoma: Are
Bispecific Antibodies Superior to CAR T Cell Therapy?
Yes: Julio Chavez, MD | No: Aleksandr Lazaryan, MD, MPH, PhD
9:25-9:30 am Audience Interaction — Vote Now!
9:30-9:55 am Break and Exhibits
SESSION Myeloid Malignancies — Moderator: Eric Padron, MD
9:55-10:25 am State of the Art: Making Sense of the New Classification Systems for MDS
Rami Komrokji, MD
10:25-10:55 am Interactive Case Discussion: Optimal use of targeted therapy for the elderly or unfit AML patient
Onyee Chan, MD
11:00-11:30 am Debate: Worst of the worst: Should we transplant patients with p53 mutant MDS or AML
Yes: Hany Elmariah, MD, MS | No: David Sallman, MD
11:25-11:30 am Audience Interaction — Vote Now!
11:30 am-12:45 pm Networking Lunch and Exhibits
SESSION Multiple Myeloma — Moderator: Melissa Alsina, MD
12:45-1:10 pm State of the Art: Bi-specifics antibodies in myeloma: Which? How? When?
Ariel Grajales-Cruz, MD
1:10-1:35 pm Interactive Case Discussion: Optimal timing of CART-cell therapy in myeloma
Ciara Freeman, MD
1:35-2:05 pm Debate: Response-adapted approach to transplant in newly diagnosed MM: are we there yet?
Yes: Ken Shain, MD | No: Omar Castañeda-Puglianini, MD
2:05-2:10 pm Audience Interaction — Vote Now!
2:10-2:35 pm Break and Exhibits
2:35-2:45 pm Raffle Winners Announced (you must be present to win)
SESSION Hot Off the Press! — Moderator: Jeffrey Lancet, MD
2:45-3:15 pm Myeloid Diseases
Presenter: Andrew Kuykendall, MD
Panel: Rami Komrokji, MD; Onyee Chan, MD; David Sallman, MD
3:15-3:45 pm Lymphoid Diseases
Presenter: Bijal Shah, MD
Panel: Hayder Saeed, MD; Julio Chavez, MD; Javier Pinilla, MD; and Aleksandr Lazaryan, MD
3:45-4:15 pm Plasma Cell Dyscrasias
Presenter: Rachid Baz, MD
Panel: Melissa Alsina, MD; Kenneth Shain, MD, PhD; Ariel Grajales-Cruz, MD
4:15-4:30 pm Closing RemarkS
